CF Industries (CF) is a U.S. producer of nitrogen fertilizers, including ammonia, urea, and liquid nitrogen solutions. Freedom analysts recommend the stock as a “Buy”: low production costs, a global fertilizer shortage, and strong cash flow support the investment case.
Investment thesis factors:
- Affordable gas supports profitability. Natural gas is a key input for ammonia production. In Q3, CF’s average gas cost was $2.88 per million British thermal units. European competitors face higher costs: management estimates that in October about 37% of the region’s ammonia capacity was idle or operating with restrictions. This supports CF’s competitive position and fertilizer prices.
- Supply deficit may persist through 2027. Management estimates that since the start of the conflict in the Middle East, the global market has missed about 9 million tons of urea supply. Even if hostilities cease, restoring export flows from the Persian Gulf may take four to six months. Low inventories and pre-buying ahead of the spring planting season could support prices in the first half of 2027.
- Financial results confirm business resilience. In Q3, CF’s revenue rose 12% year over year to $1.86 billion, and adjusted EBITDA increased 25% to $833 million. Free cash flow over the last 12 months totaled $2.03 billion. This enables the company to invest in production and return capital to shareholders.
- Yazoo City recovery will increase available capacity. After the accident, part of the complex in Mississippi remains shut down. A phased restart is scheduled for the end of the first half of 2027. It should reduce purchases of ammonia from third-party producers and additional costs. Although the recovery is beyond the idea’s two-month horizon, confirmation of the timeline could support investor expectations.
- Valuation and share buybacks provide additional support. The enterprise value-to-forward EBITDA multiple is about 6.5 versus the two-year median of 7.6. Analysts believe the market is not fully factoring in the durability of CF’s margins. In Q3, the company repurchased $367 million of shares, and over the last 12 months reduced the share count by about 6%.
Target price: $134